We are live on !
Find out more
John Rogers Ariel Investments
AUM
$9.6B
Turnover
13.64%
1-Year Est. Return
22.21%
John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+22.21%
3 Year Est. Return
+85.07%
5 Year Est. Return
+79.68%
10 Year Est. Return
+259.54%
AUM
$8.51B
AUM Growth
+$34.3M
(+0.41%)
Cap. Flow
-$436M
Cap. Flow % of AUM
Cap. Flow %
-5.12%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
200
New
10
Increased
51
Reduced
107
Closed
12
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$55.9M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$53M |
| 3 |
Charles River Laboratories
CRL
|
+$41.1M |
| 4 |
Nokia
NOK
|
+$28.4M |
| 5 |
Occidental Petroleum
OXY
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HAR
Harman International Industries
HAR
|
+$115M |
| 2 |
Kennametal
KMT
|
+$55.4M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$40.9M |
| 4 |
AXE
Anixter International Inc
AXE
|
+$40.7M |
| 5 |
CEB
CEB Inc.
CEB
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.92% |
| 2 | Communication Services | 15.18% |
| 3 | Industrials | 14.88% |
| 4 | Healthcare | 13.96% |
| 5 | Technology | 12.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Lazard
LAZ
$4.34B
| $277M | 3.26% |
6,020,949
-462,426
| -7% | -$19.9M |
2013 Q2
15 quarters
|
|
|
2
Kennametal
KMT
$1.85B
| $227M | 2.67% |
5,778,984
-1,504,834
| -21% | -$55.4M |
2014 Q2
11 quarters
|
|
3
First American
FAF
$6.62B
| $216M | 2.54% |
5,503,113
-8,828
| -0.2% | -$338K |
2013 Q2
15 quarters
|
|
4
Labcorp
LH
$30.1B
| $200M | 2.36% |
1,625,360
-86,116
| -5% | -$10.2M |
2014 Q1
12 quarters
|
|
5
Baidu
BIDU
$26.6B
| $192M | 2.25% |
1,111,024
+64,821
| +6% | +$11.4M |
2013 Q2
15 quarters
|
|
|
6
Charles River Laboratories
CRL
$16.2B
| $185M | 2.18% |
2,060,420
+483,564
| +31% | +$41.1M |
2013 Q2
15 quarters
|
|
7
DELISTED
Interpublic Group of Companies
IPG
| $185M | 2.17% |
7,517,443
-122,117
| -2% | -$2.93M |
2013 Q2
15 quarters
|
|
8
Northern Trust
NTRS
$32.3B
| $180M | 2.12% |
2,080,359
-70,093
| -3% | -$6.09M |
2013 Q2
15 quarters
|
|
|
9
Nokia
NOK
$45.7B
| $175M | 2.06% |
32,372,988
+5,650,498
| +21% | +$28.4M |
2013 Q2
15 quarters
|
|
10
Zebra Technologies
ZBRA
$15.3B
| $174M | 2.05% |
1,907,004
-232,833
| -11% | -$20.2M |
2013 Q4
13 quarters
|
|
11
Microsoft
MSFT
$3.89T
| $168M | 1.97% |
2,548,452
-89
| -0% | -$5.7K |
2013 Q2
15 quarters
|
|
12
KKR & Co
KKR
$87.5B
| $159M | 1.87% |
8,733,093
-1,624,362
| -16% | -$28.9M |
2013 Q2
15 quarters
|
|
|
VIAB
13
DELISTED
Viacom Inc. Class B
VIAB
| $158M | 1.86% |
3,387,566
-306,195
| -8% | -$12.9M |
2013 Q2
15 quarters
|
|
14
Jones Lang LaSalle
JLL
$16.8B
| $157M | 1.85% |
1,410,396
-144,026
| -9% | -$15.7M |
2013 Q2
15 quarters
|
|
|
BRS
15
DELISTED
Bristow Group, Inc.
BRS
| $155M | 1.82% |
10,160,521
+371,009
| +4% | +$6.24M |
2013 Q2
15 quarters
|
|
|
MSGN
16
DELISTED
MSG Networks Inc.
MSGN
| $146M | 1.72% |
6,251,368
-293,794
| -4% | -$6.57M |
2015 Q4
5 quarters
|
|
17
DELISTED
TEGNA Inc
TGNA
| $141M | 1.66% |
8,596,820
-1,326,621
| -13% | -$20.4M |
2013 Q2
15 quarters
|
|
18
J.M. Smucker
SJM
$14.2B
| $137M | 1.61% |
1,043,291
-40,487
| -4% | -$5.5M |
2013 Q2
15 quarters
|
|
19
Keysight
KEYS
$50.7B
| $135M | 1.58% |
3,722,785
+402,761
| +12% | +$15M |
2016 Q4
1 quarter
|
|
|
20
Bio-Rad Laboratories Class A
BIO
$9.9B
| $134M | 1.58% |
674,360
-212,467
| -24% | -$40.9M |
2013 Q2
15 quarters
|
|
21
Zimmer Biomet
ZBH
$19.5B
| $132M | 1.55% |
1,109,215
-54,225
| -5% | -$6.15M |
2013 Q2
15 quarters
|
|
22
Mattel
MAT
$4.32B
| $130M | 1.53% |
5,073,346
+612,807
| +14% | +$16.4M |
2015 Q2
7 quarters
|
|
23
Gilead Sciences
GILD
$208B
| $122M | 1.44% |
1,800,201
+216,002
| +14% | +$15.2M |
2013 Q2
15 quarters
|
|
24
CBRE Group
CBRE
$38.4B
| $120M | 1.42% |
3,463,449
-358,307
| -9% | -$12M |
2013 Q2
15 quarters
|
|
25
Aflac
AFL
$63.1B
| $117M | 1.37% |
3,218,684
-28,854
| -0.9% | -$1.02M |
2013 Q2
15 quarters
|
|
Similar funds
SC
John Rogers's Q1 2017 Portfolio in Review
As of Q1 2017, John Rogers held 200 positions worth $8.51B, up 0.41% from $8.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
John Rogers withdrew a net $436M in Q1 2017, closing 12 positions and reducing 107 holdings. Its most notable exit was Harman International Industries, an estimated $115M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, John Rogers opened a new position in Nielsen Holdings plc worth $51.2M.
- John Rogers's largest Q1 2017 buy was Nielsen Holdings plc: 1,238,592 shares worth $51.2M.
- John Rogers added most to Cardinal Health in Q1 2017, an estimated $55.9M increase.
- John Rogers's biggest Q1 2017 reduction was Kennametal, cutting an estimated $55.4M.
- John Rogers fully exited Harman International Industries in Q1 2017, selling an estimated $115M.
- John Rogers's ten largest holdings make up 24% of its $8.51B portfolio in Q1 2017.
- John Rogers opened 10 new positions and closed 12 in Q1 2017.
- John Rogers's portfolio value rose 0.41% quarter-over-quarter to $8.51B.
Based on Ariel Investments's 13F filing for Q1 2017, filed 11 May 2017.